DLA Piper advised Custom Health Inc., while Greenberg Traurig advised Berenson Acquisition Corp. on the deal. Custom Health Inc, a digital healthcare firm, announced its business...
Custom Health’s Business Combination with Berenson Acquisition Corp.
Axsome Therapeutics’ US$225 Million Shares Public Offering
DLA Piper advised Axsome Therapeutics on the offering. Axsome Therapeutics, Inc. (Axsome), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Iovance Biotherapeutics’ $200 Million Acquisition of Proleukin
DLA Piper advised Iovance Biotherapeutics in the deal. Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) announced its definitive agreement with Clinigen Limited to acquire Proleukin® (aldesleukin), an interleukin-2...
Axsome Therapeutics’ Acquisition of Sunosi
DLA Piper represented Axsome Therapeutics in the transaction. Axsome Therapeutics, a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, announced...